Even the meeting between Prime Minister Narendra Modi and Chinese President Xi Jinping in Russia’s Kazan, does not portend “peace”—at least not yet, or if at all. At the most we can describe the current thaw as a breather, primarily because the nature of China does not inspire confidence. Post the clash in Galwan in mid June 2020, when India stood up to China, the latter started insisting that the border issue should be put on the back burner and it should be business as usual. India was clear that without the border issue “resolved” there was no going ahead with business. Since the border issue seems to have been resolved to a certain extent, there may be resumption of some business, but the risk is that Chinese will flood the Indian markets with cheap goods—not that dumping had stopped in the intervening period of 2020 to 2024. The trade deficit between the two countries is tilted in China’s favour and ranges around $40 billion in the first half of 2024. To stop dumping will not be easy.
This story is from the October 24, 2024 edition of The Daily Guardian.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the October 24, 2024 edition of The Daily Guardian.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Zimbabwe fined for slow overate in 3rd T20I against Afghanistan
The host’s Zimbabwe were penalised for slow overate during the third and final T20I of the three-match series against Afghanistan at the Harare Sports Club.
Williamson hits 33rd ton; NZ set 658 to win vs England
New Zealand batter Kane Williamson scored his 33rd Test century as the Black Caps strengthened their hold in the third and final Test against England in Hamilton on Monday.
INDIA TRAIL AUSTRALIA BY 394 RUNS AT GABBA
Most of Most of the third session was washed out as the rain continued to fall throughout the session.the third session was washed out as the rain continued to fall
'It's a team in transition, won't point fingers at other'
After a disappointing day with the bat during the third Test at Brisbane, Indian pacer Jasprit Bumrah defended the team's disappointing show, saying that the \"team is in transition\".
It's not just about chess, there's lot of emotional pressure too
World Chess champion D Gukesh said that the title win was not just because of good strategy on the board, but he also credited mental conditioning coach Paddy Upton for helping him deal with the emotional pressure.
SECRET TO UNDERSTAND THE GITA
Srila Prabhupada says. The Bhagavad Gita is complete in its presentation. Bhagavad Gita is teaching us something, right? And Srila Prabhupada says, Bhagavad Gita teaches us the science of God. Krishna is the teacher, and Arjuna is the student.
SAVE BUT BE SAFE
While Paglot Baba and one of his disciples were sitting by the river, they noticed a man nearby saving a scorpion from drowning. However, as the man brought the scorpion to safety, the latter stung his hand.
Trust in God's ultimate plan for us
Each of us was created by God, who is the author of our lives. Because we were created by God, God knows how each of our journeys will end. It is the journey from the beginning to the end that needs to unfold. Some parts of our lives are laid out already by actions we committed in the past. We also have some free will in which we can make choices about what happens along the way.
IS YOUR WINTER SKIN FLAKING BECAUSE OF THE SKINCARE PRODUCTS YOU'RE USING? TIME TO INVESTIGATE THE INGREDIENTS!
Winter can be a challenging time for your skin. The drop in temperature, lower humidity levels, and indoor heating often strip the skin of its natural moisture, leaving it dry, dull, and sometimes irritated.
The Cancer Foundation and University of Chicago conclude workshop on clinical trial excellence
BCPBF-The Cancer Foundation, in collaboration with the University of Chicago, successfully concluded a two-day workshop focused on clinical trial excellence at the University of Chicago Center in Delhi.
